Author

Melisa Farias Gonzalez

Observed names: M Gonzalez, Melisa Farias-Gonzalez

Institutions: Institute for Research in Immunology and Cancer, Université de Montréal

Observed institutions: Centre Hospitalier Universitaire Vaudois, Institute for Research in Immunology and Cancer, Université de Montréal

OpenAlex ID: A5012003102

Spatial multi-omics resolve epithelium-fibroblast gradients and highlight NESTIN-NOTCH1-expressing subepithelial fibroblasts during human pancreatic tumorigenesis

2026 · Maëlle Batardière, Myriam Iliana Ibanez-Rios, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Nanofilament immunotherapy induces potent antitumor vaccine responses

2025 · Kevin Neil, Samuel Génier, et al. · Journal for ImmunoTherapy of Cancer · 1

The Value of PET-CT in Predicting the Response of Stage III N2 Non-Small Cell Lung Cancer Managed by Neoadjuvant Chemo-Immunotherapy

2025 · L E Chriqui, Z Maged, et al. · British journal of surgery · 1

Abstract 286: Multiplex imaging of human pancreatic tumors reveal novel dynamics of dysplastic stem cells, remodeling of associated fibroblasts and cell-to-cell spatial dependencies

2024 · Maëlle Batardière, Shoukari Ayman, et al. · Cancer Research

Photodynamique therapy relieves tumor vascular anergy and promotes immune cell trafficking in an orthotopic mouse model of malignant pleural mesothelioma

2022 · L E Chriqui, Y Hao, et al. · British journal of surgery

The Prembion® pre-biotic improves the impact of anti-CTLA4 immune checkpoint inhibitor in a murine model of malignant pleural mesothelioma

2022 · C Gattlen, L-E Chriqui, et al. · British journal of surgery

Works count: 6

Citation count: 3

H-index: 1

I10-index: